By correlation analysis between GPR65 and clinicopathological features, we found that the expression of GPR65 gene was higher in the early stage of LUAD than in the middle and late stages, which suggested that the heterogeneity within the tumor might suppress the expression of this gene in the late stage of LUAD. Here, GPR65 is linked to neoplasm.